🇺🇸 FDA
Patent

US 6867022

Replication deficient adenovirus vectors and methods of making and using them

expired A61KA61K48/00

Quick answer

US patent 6867022 (Replication deficient adenovirus vectors and methods of making and using them) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K48/00